Atresmedia sells its remaining Fever stake for about €227 million
Venture Map 2 firms2 outlets ShowHide
In this story 2
Coverage 2
- Capital-Riesgo.esOriginal on Capital-Riesgo.es (opens in a new tab) 16 Sep
- WebcapitalriesgoOriginal on Webcapitalriesgo (opens in a new tab) 15 Sep
The story so far, in brief; the legwork, and the full article, stay with the original outlet.
Atresmedia has sold its entire stake in Fever Labs, Inc., a holding above 5%, for roughly €227 million, it told Spain's securities regulator, the CNMV. The sale brings a net after-tax gain of about €205 million. The buyer is reported to be Vitruvian Partners, already among Fever's investors.
The position began in 2015 as a media-for-equity deal with Fever's Spanish subsidiary, shares in exchange for advertising, and Atresmedia joined Fever Labs, Inc.'s capital in 2018.
Counting earlier sales in 2023 and 2024, Atresmedia has taken in about €296 million from Fever, for an after-tax profit of roughly €264 million. That is a fair amount of money for something that started as airtime.

